Uncharged tRNA-phosphofructokinase interaction in amino acid deficiency

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Incomplete tRNA charging, due to amino acid deficiency or analogs, limits mammalian cell metabolic events.
• Uncharged tRNA inhibits phosphofructokinase (PFK), a key glycolytic enzyme, leading to rapid cell function decline.
• Charged tRNA is sequestered in the protein synthetic machinery, preventing its inhibitory role.

Purpose of the Study:

• To elucidate the mechanism by which incomplete tRNA charging affects cell metabolism and function.
• To investigate the role of uncharged tRNA as an inhibitor of phosphofructokinase (PFK).
• To explore the link between PFK activity, protein synthesis, and cell cycle regulation.

Main Methods:

• Direct demonstration of tRNA inhibition of PFK in vitro.
• Analysis of cellular responses to amino acid deficiency, including glycolysis and glucose uptake.
• Correlation of cAMP concentrations with protein synthesis stimulation and PFK activity.
• Examination of fructose-1,6-diphosphate's role in protein synthesis and its interaction with eIF-2B.

Main Results:

• Uncharged tRNA directly inhibits phosphofructokinase (PFK) activity.
• Amino acid deficiency rapidly inhibits glycolysis and glucose uptake in intact cells.
• High cAMP concentrations stimulate protein synthesis in lysates by acting as a PFK analog.
• Fructose-1,6-diphosphate, a PFK product, stimulates protein synthesis by activating the eIF-2B guanine nucleotide exchange factor.

Conclusions:

• The phosphofructokinase-uncharged tRNA mechanism explains the G1 cell cycle block caused by amino acid deprivation.
• Inhibition of protein synthesis via PFK and uncharged tRNA is a key consequence of amino acid deficiency.
• Tumor and transformed cells, resistant to cell cycle blocks, exhibit higher PFK activity and fructose-1,6-diphosphate levels.